Abstract:Ying-Hua Luo, 1, &ast Cheng Wang, 2, &ast Wan-Ting Xu, 3, &ast Yu Zhang, 3 Tong Zhang, 3 Hui Xue, 3 Yan-Nan Li, 3 Zhong-Ren Fu, 3 Ying Wang, 4 Cheng-Hao Jin 3– 5 1 Department of Grass Science, College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, 163319, People's Republic of China; 2 Pharmacy Department, Daqing Oilfield General Hospital, Daqing, 163001, People's Republic of China; 3 Department of Biochemistry and Molecular Biology, College of Life Science & Technology, Heilongjiang Bayi Agricultural University, Daqing, 163319, People's Republic of China; 4 College of Food Science and Technology, Heilongjiang Bayi Agricultural University, Daqing, 163319, People's Republic of China; 5 National Coarse Cereals Engineering Research Center, Daqing, 163319, People's Republic of China &astThese authors contributed equally to this work Correspondence: Cheng-Hao Jin; Ying Wang Email ; Background: 18β-glycyrrhetinic acid (18β-Gly), which is extracted from licorice root, has various pharmacological properties; however, its anti-cancer effects on lung cancer cells have not been fully established. Purpose: In this study, we investigated the underlying molecular mechanisms of 18β-Gly. Results: Our results showed that 18β-Gly had significant cytotoxic effects and no apparent side effects. 18β-Gly induced mitochondria-dependent apoptosis of A549 lung cancer cells. In addition, after treatment with 18β-Gly, intracellular reactive oxygen species (ROS) levels were significantly increased, and G2/M cell cycle arrest and inhibition of cell migration were induced via the mitogen-activated protein kinase (MAPK)/signal transducer and activator of transcription 3 (STAT3)/nuclear factor kappa (NF-κB) signaling pathways. After pretreatment with the ROS scavenger N-acetyl-L-cysteine or MAPK inhibitors, the expression levels of phosphorylated p38 (p-p38), phosphorylated c-Jun N-terminal kinase, inhibitor of nuclear factor kappa B, cleaved caspase-3 (cle-cas-3), cleaved poly (ADP ribose) polymerase (cle-PARP), p-p53, p27, p21, and E-cadherin were decreased; and levels of phosphorylated extracellular signal-regulated kinase, p-STAT3, NF-κB, Bcl-2, cyclin B1, cyclase-dependent kinase 1/2 (CDK1/2), N-cadherin, vimentin, and snail homolog 1 (SNAI 1) were increased. In addition, the percentage of cells in the G2/M phase was decreased, and inhibition of migration was reduced. Conclusion: In summary, 18β-Gly induced apoptosis and G2/M cell cycle arrest and inhibited migration via the ROS/MAPK/STAT3/NF-κB signaling pathways in A549 lung cancer cells. Therefore, 18β-Gly is a novel promising candidate for the treatment of lung cancer. Keywords: 18β-glycyrrhetinic acid, lung cancer, apoptosis, cell cycle arrest, ROS, cell migration Lung cancer is one of the most common malignant tumors, with a morbidity and mortality that has rapidly increased globally in recent decades. 1 Despite advances in early detection and treatment strategies for lung cancer, the 5-year survival rate is still below 20%. 2 Treatment options for lung cancer included surgery, chemotherapy, radiation therapy, or a combination. In addition, systemic chemotherapy is commonly used to treat advanced lung cancer by controlling symptoms and prolonging survival. 3 Despite improved chemotherapy, long-term survival in patients with advanced lung cancer remains low. 4 Therefore, it is important to study the pathogenesis and molecular mechanisms of lung cancer, and to identify novel therapeutic drugs with high anti-cancer efficacy and few side effects. In recent years, natural compounds derived from traditional Chinese medicines have become a research hotspot in the development of highly effective anti-cancer drugs with few side effects. 5,6 18β-glycyrrhetinic acid (18β-Gly) is the major bioactive component of Glycyrrhizae Radix, possessing antiulcerative, anti-inflammatory, and antiproliferative properties. 7–9 In addition, 18β-Gly inhibits migration and invasion via the reactive oxygen species (ROS)/protein kinase C-alpha/ERK pathways in human gastric cancer cells. 10 However, to date, the effects of 18β-Gly on lung cancer remain unclear. ROS, mainly produced by mitochondria, play an important role in various signaling pathways. 11 Most research has focused on the regulatory relationship between ROS and downstream signaling pathways. 12,13 Mitogen-activated protein kinase (MAPK) and p53 are two important downstream molecules regulated by ROS, and are involved i -Abstract Truncated-

Correction to Novel Ligustrazine-Based Analogs of Piperlongumine Potently Suppress Proliferation and Metastasis of Colorectal Cancer Cells in Vitro and in Vivo.

Correction to “Lactoferrin-Modified Gambogic Acid Liposomes for Colorectal Cancer Treatment”

Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer

Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues As Potent and Selective Antitumor Agents.

Correction: Characterization of a small-molecule inhibitor targeting NEMO/IKKβ to suppress colorectal cancer growth

Piperlonguminine and Piperine Analogues as TrxR Inhibitors that Promote ROS and Autophagy and Regulate p38 and Akt/mTOR Signaling

Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors Via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance

Mesoporous Silica Nanoparticles Carrying Ligustrazine Inhibit Metastatic Properties of Colon Cancer Cells

Total Synthesis of Methyl Protodioscin: A Potent Agent with Antitumor Activity.

Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells

Correction to “design, Synthesis, and Bioactivity Evaluation of Dual-Target Inhibitors of Tubulin and Src Kinase Guided by Crystal Structure”

Correction to “hyaluronan Reduces Cationic Liposome-Induced Toxicity and Enhances the Antitumor Effect of Targeted Gene Delivery in Mice”

Correction to Intracellular Fate of Nanoparticles with Polydopamine Surface Engineering and a Novel Strategy for Anti-Exocytosis Enhanced, Lysosome Impairment-Based Cancer Therapy

Ligustilide Inhibits the PI3K/AKT Signalling Pathway and Suppresses Cholangiocarcinoma Cell Proliferation, Migration, and Invasion

Mechanism of luteolin against non-small-cell lung cancer: a study based on network pharmacology, molecular docking, molecular dynamics simulation, and in vitro experiments

18β-Glycyrrhetinic Acid Has Anti-Cancer Effects via Inducing Apoptosis and G2/M Cell Cycle Arrest, and Inhibiting Migration of A549 Lung Cancer Cells

Piperlongumine Induces Gastric Cancer Cell Apoptosis and G2/M Cell Cycle Arrest Both in Vitro and in Vivo.

[Corrigendum] Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP‐2 and MMP‐9 expression via the p38MAPK signaling pathway

Network pharmacology‐based analysis and in vitro experimental verification of the inhibitory role of luteoloside on gastric cancer cells via the p53/p21 pathway

Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.